Suchergebnisse - "rucaparib"

PubPharm (303)

1

Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model

enthalten in: Anticancer research | 2024

von Morea, A. | Saravi, S. | Sisu, C. | +4

2

enthalten in: Aktuelle Urologie | 2024

3

enthalten in: Aktuelle Urologie | 2024

4

A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)

enthalten in: The oncologist | 2024

von Sahu, K. | Li, H. | Mathew Thomas, V. | +7

5

PARP inhibitor era in ovarian cancer treatment : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Journal of ovarian research | 2024

von Baradács, I. | Teutsch, B. | Váradi, A. | +9

6

PARP Inhibitors : Strategic Use and Optimal Management in Ovarian Cancer

enthalten in: Cancers | 2024

von Hirschl, N. | Leveque, W. | Granitto, J. | +3

7

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

enthalten in: Cell chemical biology | 2024

von Hu, H. | Serra, C. | Zhang, W. | +7

8

Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation : a systematic review and meta-analysis of phase III randomized clinical trials

enthalten in: Expert review of anticancer therapy | 2024

von Mustafa, M. | Abushanab, A. | Mousa, M. | +4

9

Development of PARP inhibitors in advanced prostate cancer

enthalten in: Therapeutic advances in medical oncology | 2024

von Bourlon, M. | Valdez, P. | Castro, E.

10

The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy

enthalten in: Genes & diseases | 2024

von Yao, F. | Zhong, F. | Jiang, J. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]